Published in Vaccine Weekly, June 7th, 2000
"Covalent linkage of a bacterial polysaccharide to an immunogenic protein greatly enhances the carbohydrates immunogenicity and induces polysaccharide-specific B-cell memory in vivo," said Arlene H. Guttormsen and colleagues at Harvard Medical School, Massachusetts. "These findings have supported the development of glycoconjugate vaccines for serious bacterial infections."
Guttormsen et al. presented data from their study at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.